Interleukin-17: a mediator of inflammatory responses - PubMed (original) (raw)

Review

Interleukin-17: a mediator of inflammatory responses

J Witowski et al. Cell Mol Life Sci. 2004 Mar.

Abstract

Interleukin-17 (IL-17) is a prototype member of a new cytokine family with six species identified to date. IL-17 is secreted mainly by activated CD4(+) and CD8(+) T lymphocytes, while its receptor is distributed ubiquitously. IL-17 has been classified as a proinflammatory cytokine because of its ability to induce the expression of many mediators of inflammation, most strikingly those that are involved in the proliferation, maturation and chemotaxis of neutrophils. Increased levels of IL-17 have been associated with several conditions, including airway inflammation, rheumatoid arthritis, intraperitoneal abscesses and adhesions, inflammatory bowel disease, allograft rejection, psoriasis, cancer and multiple sclerosis. This review provides an overview of IL-17 activities, concentrating on those that lead to neutrophil recruitment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circulation. 1982 Jun;65(7):1299-306 - PubMed
    1. Am J Cardiol. 1999 Jul 1;84(1):96-8, A8 - PubMed
    1. Prog Cardiovasc Dis. 1982 Nov-Dec;25(3):169-92 - PubMed
    1. Circulation. 2006 Apr 18;113(15):1888-904 - PubMed
    1. J Invasive Cardiol. 2002 Oct;14(10):633-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources